"Misoprostol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties.
| Descriptor ID |
D016595
|
| MeSH Number(s) |
D10.251.355.255.550.775.450.500 D23.469.050.175.725.775.450.500 D23.469.700.660.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Misoprostol".
Below are MeSH descriptors whose meaning is more specific than "Misoprostol".
This graph shows the total number of publications written about "Misoprostol" by people in this website by year, and whether "Misoprostol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 3 | 0 | 3 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 3 | 0 | 3 |
| 2021 | 2 | 0 | 2 |
| 2022 | 4 | 0 | 4 |
| 2023 | 3 | 0 | 3 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Misoprostol" by people in Profiles.
-
Bender WR, Mccoy JA, Levine LD. Oxytocin vs oral misoprostol for PROM induction in nulliparas with unfavorable cervix: a randomized trial. Am J Obstet Gynecol MFM. 2024 08; 6(8):101414.
-
Gomez Slagle HB, Kawakita T, Hoffman MK, Sciscione AC, Ma'ayeh M. Buccal versus Vaginal Misoprostol Combined with a Foley Catheter among Individuals with Obesity Undergoing Induction. Am J Perinatol. 2024 10; 41(13):1748-1754.
-
Bleck RR, Danvers AA, Nimbvikar A, Gurney EP. Medical management of early pregnancy loss with mifepristone and misoprostol in emergency departments compared to a Complex Family Planning office: Implementation of a COVID-19 institutional policy change. Contraception. 2024 08; 136:110467.
-
Al-Hafez L, Khanuja K, Mendez-Figueroa H, Al-Kouatly HB, Mascio DD, Chauhan SP, Berghella V. Misoprostol with balloon vs oxytocin with balloon in high-risk pregnancy induction: a randomized controlled trial. Am J Obstet Gynecol MFM. 2023 12; 5(12):101175.
-
Bromwich KA, McCoy JA, Cahill AG, Sciscione AC, Levine LD. Association between intracervical Foley balloon and clinical chorioamnionitis among patients with group B streptococcus colonization undergoing induction with standardized labor management. Am J Obstet Gynecol MFM. 2023 11; 5(11):101167.
-
Sanchez-Ramos L, Levine LD, Sciscione AC, Mozurkewich EL, Ramsey PS, Adair CD, Kaunitz AM, McKinney JA. Methods for the induction of labor: efficacy and safety. Am J Obstet Gynecol. 2024 03; 230(3S):S669-S695.
-
Angarita AM, Cochrane E, Bianco A, Berghella V. Prevention of postpartum hemorrhage in vaginal deliveries. Eur J Obstet Gynecol Reprod Biol. 2023 Jan; 280:112-119.
-
Ferguson GP, Achilles SL, Meyn LA, Krajewski CM, Chappell CA, Vinekar K, Chen BA. Dextromethorphan as a novel nonopioid adjunctive agent for pain control with medication abortion: A randomized controlled trial. Contraception. 2023 02; 118:109908.
-
Angarita AM, Berghella V. Evidence-based labor management: third stage of labor (part 5). Am J Obstet Gynecol MFM. 2022 09; 4(5):100661.
-
Gomez Slagle HB, Fonge YN, Caplan R, Pfeuti CK, Sciscione AC, Hoffman MK. Early vs expectant artificial rupture of membranes following Foley catheter ripening: a randomized controlled trial. Am J Obstet Gynecol. 2022 05; 226(5):724.e1-724.e9.